1158803-51-0

Basic information

• Product Name: 4-(pyrrolidin-1-yl)butyl 2-(4-((2-amino-4-(butylamino)-6-methylpyrimidin-5-yl)methyl)phenyl)acetate
• Synonyms: 4-(pyrrolidin-1-yl)butyl 2-(4-((2-amino-4-(butylamino)-6-methylpyrimidin-5-yl)methyl)phenyl)acetate
• CAS NO: 1158803-51-0
• Molecular Weight: 453.628
• Mol File: 1158803-51-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(pyrrolidin-1-yl)butyl 2-(4-((2-amino-4-(butylamino)-6-methylpyrimidin-5-yl)methyl)phenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(pyrrolidin-1-yl)butyl 2-(4-((2-amino-4-(butylamino)-6-methylpyrimidin-5-yl)methyl)phenyl)acetate(1158803-51-0)
• EPA Substance Registry System: 4-(pyrrolidin-1-yl)butyl 2-(4-((2-amino-4-(butylamino)-6-methylpyrimidin-5-yl)methyl)phenyl)acetate(1158803-51-0)

Safety Data

• Hazardous Substances Data: 1158803-51-0(Hazardous Substances Data)

Upstream product

• 93264-47-2 4-(pyrrolidin-1-yl)butan-1-ol 
• 1158804-59-1 2-(4-((2-amino-4-(butylamino)-6-methylpyrimidin-5-yl)methyl)phenyl)acetic acid 

Relevant articles and documents

PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA, COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, BACTERIAL INFECTIONS AND DERMATOSIS

The present invention provides compounds of formula (I) wherein R 1, R2, R3 and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.